The Excalibur-project consists of 3 randomized control trials, Excalibur 1-3, and is conducted at Oslo University Hospital, Department of HPB-surgery. The project aims to increase overall survival for patients with extensive colorectal livermetastasis and insufficient response to 1st line chemotherapy. This group have a dismal prognosis, with current OS at 10-14 months.   More...